Alberto Lleó

Active 2001–2026

239
Papers
31,117
Citations
91
h-index
226
i10-index

Citations

Citations per year for Alberto Lleó1992: 1 citations2002: 2 citations2003: 2 citations2004: 2 citations2005: 23 citations2006: 33 citations2007: 29 citations2008: 17 citations2009: 32 citations2010: 47 citations2011: 46 citations2012: 79 citations2013: 54 citations2014: 169 citations2015: 252 citations2016: 372 citations2017: 457 citations2018: 532 citations2019: 1,383 citations2020: 1,665 citations2021: 1,677 citations2022: 1,521 citations2023: 1,285 citations2024: 2,183 citations2025: 1,445 citations2026: 35 citations1993–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,539 citing papers, 22.5% of this breakdownUnited Kingdom: 2,042 citing papers, 10.1% of this breakdownChina: 1,443 citing papers, 7.2% of this breakdownSweden: 1,085 citing papers, 5.4% of this breakdownGermany: 1,076 citing papers, 5.3% of this breakdownSpain: 1,021 citing papers, 5.1% of this breakdownNetherlands: 774 citing papers, 3.8% of this breakdownItaly: 770 citing papers, 3.8% of this breakdownCanada: 700 citing papers, 3.5% of this breakdownFrance: 698 citing papers, 3.5% of this breakdownAustralia: 590 citing papers, 2.9% of this breakdownSwitzerland: 428 citing papers, 2.1% of this breakdown
0%22.5%Other 24.8%

Fields

  • Medicine58.8%
  • Biochemistry, Genetics and Molecular Biology18.9%
  • Neuroscience15.7%
  • Immunology and Microbiology1.5%
  • Computer Science1%
  • Psychology0.8%
  • Other3.3%

Topics

  • Alzheimer's disease research and treatments16%
  • Dementia and Cognitive Impairment Research9%
  • Neuroinflammation and Neurodegeneration Mechanisms5.5%
  • Parkinson's Disease Mechanisms and Treatments2.8%
  • Amyotrophic Lateral Sclerosis Research2.2%
  • Genetic Associations and Epidemiology2.1%
  • Other62.4%

Coauthors

All papers

Open in search
  1. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Seung‐Hoan Choi, Christiane Reitz, Florence Pasquier, Paul Hollingworth, Alfredo Ramı́rez, Olivier Hanon, Annette L. Fitzpatrick, Joseph D. Buxbaum, Dominique Campion, Paul K. Crane, Clinton T. Baldwin, Tim Becker, Vilmundur Guðnason, Carlos Cruchaga, David Craig, Najaf Amin, Claudine Berr, Oscar L Lopez, Philip L. De Jager, Vincent Deramecourt, Janet Johnston, Denis A. Evans, Simon Lovestone, Luc Letenneur, Francisco Jesús Morón, David C. Rubinsztein, Gudny Eiriksdottir, Kristel Sleegers, Alison Goate, Nathalie Fiévet, Matthew J. Huentelman, Michael Gill, Kristelle Brown, M. Ilyas Kamboh, Lina Keller, Pascale Barberger‐Gateau, Bernadette McGuinness, Eric B. Larson, Robert C. Green, Amanda Myers, Carole Dufouil, Stephen Todd, David Wallon, Seth Love, Ekaterina Rogaeva, John Gallacher, Peter St George‐Hyslop, Jordi Clarimón, Alberto Lleó, Anthony Bayer, Debby W. Tsuang, Lei Yu, Magda Tsolaki, Paola Bossù, Gianfranco Spalletta, Petroula Proitsi, John Collinge, Sandro Sorbi, Florentino Sánchez-García, Nick C. Fox, John Hardy, María Cándida Déniz Naranjo, Paolo Bosco, Robert Clarke, Carol Brayne, Daniela Galimberti, Michelangelo Mancuso, Fiona E. Matthews, Susanne Moebus, Patrizia Mecocci and 84 more - Nature Genetics 2013 cited by 4,659

  2. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2024 cited by 768

  3. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wiesje M. van der Flier, Lisa Ford, Stefan Förster, Juan Fortea, Nadia Foskett, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Giovanni B. Frisoni, Lutz Froelich, Tomasz Gabryelewicz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Mark Forrest Gordon, Timo Grimmer, Harald Hampel, Lucrezia Hausner, Sabine Hellwig, Sanna‐Kaisa Herukka, Helmut Hildebrandt, Lianna Ishihara, Adrian Ivanoiu, William J. Jagust, Peter Johannsen, Ramesh Kandimalla, Elisabeth Kapaki, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Sebastian Köhler, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Koen Van Laere, Susan Landau, Dong Young Lee, Mony J. de Leon, Viviana Lisetti, Alberto Lleó, Karine Madsen, Wolfgang Maier, Jan Marcusson, Niklas Mattsson, Alexandre de Mendonça, Olga Meulenbroek, Philipp T. Meyer, Mark A. Mintun, Vincent Mok, José Luís Molinuevo, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Stefan Van der Mussele, Duk L. Na, Andrew B. Newberg, Agneta Nordberg, Arto Nordlund, Gerald Novak, George P. Paraskevas, Lucilla Parnetti, Gayan Perera, Oliver Peters, Julius Popp, Sudesh Prabhakar, Gil D. Rabinovici, Inez H.G.B. Ramakers, Lorena Rami, Catarina R. Oliveira, Juha O. Rinne, Karen M. Rodrigue, Eloy Rodríguez‐Rodríguez and 29 more - JAMA 2015 cited by 1,635

  4. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C. van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye, Oskar Hansson - Nature Communications 2021 cited by 555

  5. APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

    Authors: , , , , , , , , , , , , , - Nature Medicine 2024 cited by 331

  6. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lindsay A. Farrer, María Victoria Fernández, Nick C. Fox, Daniela Galimberti, Emmanuelle Génin, Johan J. P. Gille, Yann Le Guen, Rita Guerreiro, Jonathan L. Haines, Clive Holmes, M. Arfan Ikram, M. Kamran Ikram, Iris E. Jansen, Robert Kraaij, M Lathrop, Afina W. Lemstra, Alberto Lleó, Lauren Luckcuck, Marcel M. A. M. Mannens, Iain Marshall, Eden R. Martin, Carlo Masullo, Richard Mayeux, Patrizia Mecocci, Alun Meggy, Merel O. Mol, Kevin Morgan, R Myers, Benedetta Nacmias, Adam C. Naj, Valerio Napolioni, Florence Pasquier, Pau Pástor, Margaret A. Pericak‐Vance, Rachel Raybould, Richard Redon, Marcel Reinders, Anne‐Claire Richard, Steffi G. Riedel‐Heller, Fernando Rivadeneira, Stéphane Rousseau, Natalie S. Ryan, Salha Saad, Pascual Sánchez‐Juan, Gerard D. Schellenberg, Philip Scheltens, Jonathan M. Schott, Davide Seripa, Sudha Seshadri, Daoud Sie, Erik A. Sistermans, Sandro Sorbi, Resie van Spaendonk, Gianfranco Spalletta, Niccoló Tesi, Betty M. Tijms, André G. Uitterlinden, Sven J. van der Lee, Pieter Jelle Visser, Michael Wagner, David Wallon, Li-San Wang, Aline Zaréa, Jordi Clarimón, John C. van Swieten, Michael D. Greicius, Jennifer S. Yokoyama, Carlos Cruchaga, John Hardy, Alfredo Ramı́rez and 7 more - Nature Genetics 2022 cited by 219

  7. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Hardy, Marco Colonna, Christian Haass - Science Translational Medicine 2014 cited by 837

  8. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ann D. Cohen, Alisha Daniels, Marion Delarue, Mira Didic, Alexander Drzezga, Bruno Dubois, Marie Eckerström, Laura L. Ekblad, Sebastiaan Engelborghs, Stéphane Epelbaum, Anne M. Fagan, Yong Fan, Tormod Fladby, Adam Fleisher, Wiesje M. van der Flier, Stefan Förster, Juan Fortea, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Lars Frings, Giovanni B. Frisoni, Lutz Fröhlich, Tomasz Gabryelewicz, Hermann‐Josef Gertz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Timo Grimmer, Eric Guedj, Christian Habeck, Harald Hampel, Ron Handels, Oskar Hansson, Lucrezia Hausner, Sabine Hellwig, Michael T. Heneka, Sanna‐Kaisa Herukka, Helmut Hildebrandt, John R. Hodges, Jakub Hort, Chin‐Chang Huang, Ane Iriondo, Yoshiaki Itoh, Adrian Ivanoiu, William J. Jagust, Frank Jessen, Peter Johannsen, Keith A. Johnson, Ramesh Kandimalla, Elisabeth Kapaki, Silke Kern, Lena Kilander, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Hung‐Chou Kuo, Koen Van Laere, Susan Landau, Brigitte Landeau, Dong Young Lee, Mony J. de Leon, Cristian E. Leyton, Kun‐Ju Lin, Alberto Lleó, Malin Löwenmark, Karine Madsen, Wolfgang Maier, Jan Marcusson and 83 more - JAMA Neurology 2022 cited by 288

  9. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Niels Hansen, Mathias Bähr, Inga Zerr, Agnes Flöel, Peter J. Nestor, Emrah Düzel, Wenzel Glanz, Enise I. Incesoy, Katharina Bürger, Daniel Janowitz, Robert Perneczky, Boris‐Stephan Rauchmann, Franziska Hopfner, Olivia Wagemann, Johannes Levin, Stefan Teipel, Ingo Kilimann, Doreen Göerß, Johannes Prudlo, Thomas Gasser, Kathrin Brockmann, David Mengel, Milan Zimmermann, Matthis Synofzik, Carlo Wilke, Judit Selma‐González, Janina Turón‐Sans, Miguel Santos‐Santos, Daniel Alcolea, Sara Rubio‐Guerra, Juan Fortea, Álvaro Carbayo, Alberto Lleó, Ricardo Rojas‐García, Ignacio Illán‐Gala, Michael Wagner, Ingo Frommann, Sandra Roeske, L Bertram, Michael T. Heneka, Frederic Brosseron, Alfredo Ramı́rez, Matthias Schmid, Rudi Beschorner, Annett Halle, Jochen Herms, Manuela Neumann, Nicolas R. Barthélemy, Randall J. Bateman, Patrizia Rizzu, Peter Heutink, Oriol Dols‐Icardo, Günter U. Höglinger, Andreas Hermann, Anja Schneider - Nature Medicine 2024 cited by 185

  10. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2020 cited by 337

  11. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2016 cited by 530

  12. Prevalence of Amyloid PET Positivity in Dementia Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Koen Van Laere, Alexander Drzezga, Stefan Förster, Timo Grimmer, Pascual Sánchez‐Juan, J.M. Carril, Vincent Mok, Vincent Camus, William E. Klunk, Ann D. Cohen, Philipp T. Meyer, Sabine Hellwig, Andrew B. Newberg, Kristian Steen Frederiksen, Adam Fleisher, Mark A. Mintun, David A. Wolk, Agneta Nordberg, Juha O. Rinne, Gaël Chételat, Alberto Lleó, Rafael Blesa, Juan Fortea, Karine Madsen, Karen M. Rodrigue, David J. Brooks - JAMA 2015 cited by 666

  13. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Haass, Tom J. Brett, Bruno A. Benítez, Celeste M. Karch, Laura Piccio, Carlos Cruchaga - Science Translational Medicine 2019 cited by 284

  14. Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2022 cited by 186

  15. Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

    Authors: , , , , , , , , , , , , - Alzheimer s Research & Therapy 2024 cited by 128

  16. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Chemistry and Laboratory Medicine (CCLM) 2021 cited by 150

  17. Neuropsychological deficits in patients with cognitive complaints after COVID‐19

    Authors: , , , , , , , , , , , , - Brain and Behavior 2022 cited by 151

  18. Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain 2020 cited by 220

  19. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Neurology 2020 cited by 145

  20. Frontotemporal dementia and its subtypes: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jordi Clarimón, Alberto Lleó, Rafael Blesa, Maria Landqvist Waldö, Karin Nilsson, Christer Nilsson, Ian R. Mackenzie, Ging‐Yuek Robin Hsiung, David Mann, Jordan Grafman, Christopher M. Morris, Johannes Attems, Timothy D. Griffiths, Ian G. McKeith, Alan Thomas, Pietro Pietrini, Edward D. Huey, Eric M. Wassermann, Atik Baborie, Evelyn Jaros, Michael C Tierney, Pau Pástor, Cristina Razquín, Sara Ortega‐Cubero, Elena Alonso, Robert Perneczky, Janine Diehl‐Schmid, Panagiotis Alexopoulos, Alexander Kurz, Innocenzo Rainero, Elisa Rubino, Lorenzo Pinessi, Ekaterina Rogaeva, Peter St George‐Hyslop, Giacomina Rossi, Fabrizio Tagliavini, Giorgio Giaccone, James B. Rowe, Johannes C. M. Schlachetzki, James Uphill, John Collinge, Simon Mead, Adrian Danek, Vivianna M. Van Deerlin, Murray Grossman, John Q. Trojanowski, Julie van der Zee, William Deschamps, Tim Van Langenhove, Marc Cruts, Christine Van Broeckhoven, Stefano F. Cappa, Isabelle Le Ber, Didier Hannequin, Véronique Golfier, Martine Vercelletto, Alexis Brice, Benedetta Nacmias, Sandro Sorbi, Silvia Bagnoli, Irene Piaceri, Jørgen E. Nielsen, Lena E. Hjermind, Matthias Riemenschneider, Manuel Mayhaus, Bernd Ibach, Gilles Gasparoni, Sabrina Pichler, Wei Gu, Martin N. Rossor and 58 more - The Lancet Neurology 2014 cited by 402

  21. Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse

    Authors: , , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2019 cited by 196

  22. Consensus guidelines for lumbar puncture in patients with neurological diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erik Stomrud, Hayrettin Tumani, Pieter Jelle Visser, Anders Wallin, Bengt Winblad, Henrik Zetterberg, Flora H. Duits, Charlotte E. Teunissen - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2017 cited by 356

  23. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Merçé Boada, Anne Boland, Katharina Büerger, Ángel Carracedo, Laura Cervera‐Carles, Geneviève Chêne, Jurgen A.H.R. Claassen, Stéphanie Debette, Jean‐François Deleuze, Peter Paul De Deyn, Janine Diehl‐Schmid, Srdjan Djurovic, Oriol Dols‐Icardo, Carole Dufouil, Emmanuelle Duron, Emrah Düzel, Tormod Fladby, Juan Fortea, Lutz Frölich, Pablo García‐González, María García‐Martínez, Ina Giegling, Oliver Goldhardt, Johan Gobom, Timo Grimmer, Annakaisa Haapasalo, Harald Hampel, Olivier Hanon, Lucrezia Hausner, Stefanie Heilmann‐Heimbach, Seppo Helisalmi, Michael T. Heneka, Isabel Hernández, Sanna‐Kaisa Herukka, Henne Holstege, Jonas Alexander Jarholm, Silke Kern, Anne‐Brita Knapskog, Anne M. Koivisto, Johannes Kornhuber, Teemu Kuulasmaa, Carmen Lage, Christoph Laske, Ville Leinonen, Piotr Lewczuk, Alberto Lleó, Adolfo López de Munain, Sara López‐García, Wolfgang Maier, Marta Marquié, Merel O. Mol, Laura Montrreal, Fermín Moreno, Sonia Moreno–Grau, Gaël Nicolas, Markus M. Nöthen, Adelina Orellana, Lene Pålhaugen, Janne M. Papma, Florence Pasquier, Robert Perneczky, Oliver Peters, Yolande A.L. Pijnenburg, Julius Popp, Daniëlle Posthuma, Ana Pozueta, Josef Priller, Raquel Puerta, Inés Quintela, Inez Ramakers and 47 more - Acta Neuropathologica 2022 cited by 138

  24. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , - Translational Neurodegeneration 2021 cited by 89